Brief: Synact Pharma Says Current Cash, Cash Equivalents Insufficient To Meet Co's Liquidity Needs Over Next 12 Months

SynAct Pharma AB

20/08/2024 07:23

Aug 20 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * CURRENT CASH, CASH EQUIVALENTS ARE INSUFFICIENT TO MEET
CO'S
LIQUIDITY NEEDS OVER NEXT 12 MONTHS
    * BOARD EVALUATES VARIOUS FINANCIAL ALTERNATIVES INCLUDING
OPTIMAL
TIMING AND SIZE OF CAPITAL RAISE
    * BOARD HAS POSITIVE VIEW OF BEING ABLE TO CARRY OUT SUCH
CAPITAL
FUNDING

Source text for Eikon:  ID:nMFN2rsC67 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))